JOHNSON KENNETH ERLAND (See Remarks) reported 8 transactions at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Common Stock
Shares
−7.50K
Price / share
$2.11
Trade value
$15.82K
% of position
Common Stock
Shares
−2.31K
Price / share
$2.11
Trade value
$4.87K
% of position
Common Stock
Shares
−12.40K
Price / share
$1.12
Trade value
$13.89K
% of position
Common Stock
Shares
−11.03K
Price / share
$1.26
Trade value
$13.90K
% of position
Common Stock
Shares
−3.39K
Price / share
$1.24
Trade value
$4.21K
% of position
Common Stock
Shares
−12.40K
Price / share
$2.24
Trade value
$27.78K
% of position
Common Stock
Shares
−10.75K
Price / share
$2.66
Trade value
$28.59K
% of position
Common Stock
Shares
−15.13K
Price / share
$2.46
Trade value
$37.22K
% of position
Net shares
−74.90K
Net value
-$146.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2022 | F · Tax Withholding | −7.50K | $2.11 | $15.82K | 1.7% | 447.94K | 440.44K |
| Common Stock Direct | 1/31/2022 | F · Tax Withholding | −2.31K | $2.11 | $4.87K | 0.5% | 440.44K | 438.14K |
| Common Stock Direct | 1/3/2023 | F · Tax Withholding | −12.40K | $1.12 | $13.89K | 2.8% | 438.14K | 425.74K |
| Common Stock Direct | 1/29/2023 | F · Tax Withholding | −11.03K | $1.26 | $13.90K | 2.6% | 425.74K | 414.71K |
| Common Stock Direct | 1/31/2023 | F · Tax Withholding | −3.39K | $1.24 | $4.21K | 0.8% | 414.71K | 411.31K |
| Common Stock Direct | 1/3/2024 | F · Tax Withholding | −12.40K | $2.24 | $27.78K | 3.0% | 411.31K | 398.91K |
| Common Stock Direct | 1/29/2024 | F · Tax Withholding | −10.75K | $2.66 | $28.59K | 2.7% | 398.91K | 388.17K |
| Common Stock Direct | 1/31/2024 | F · Tax Withholding | −15.13K | $2.46 | $37.22K | 3.9% | 388.17K | 373.04K |
| Total | −74.90K | -$146.26K | ||||||